Angel Invest Boston · 2023-12-20 · 46 min
Aging Fit Substack: Learn More Repeat life science entrepreneur Tom Weldon is now taking on aging. He is commercializing a compound to extend health span developed at a prominent institution. Composed of substances generally considered as safe by the FDA, the formula has shown impressive results in mice and, to date, in one human, Tom himself. Intriguing chat with a dynamic founder. Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson. Highlights: Sal Daher Introduces Tom Weldon What Problem Rejuvant Addresses "... Then the first time the combination is not additive, take it out. That's a process that would probably take a year or two, but it ensures that you'll have an optimal result. Or, you can buy Rejuvant, because we did all that work already..." "... if you decide that you'd like to try Rejuvant and you go on subscription, we give you a free DNA methylation test at time zero and then we give you another one after six months, which is included in the cost ... They're different and they have different algorithms.
Sal Daher - Lessons Learned75 / 100Sal Daher - Lessons Learned - PODCAST LAUNCH DELAYED UNTIL 12/29/23 at 1:30 AM - Apologies!!Sal Daher - Startups in the IRA? Pros & Cons from Decades of InvestingRaul Rosa - Art and CraftPaul Hartung - Fund a Biotech Startup in Hard Times